Lab Sell Reversible Thrombin Inhibitors Peptide Bivalirudin Trifluoroacetate Online
Bivalirudin Trifluoroacetate Chemical Profile
Name:Bivalirudin Trifluoroacetate
Cas No:128270-60-0(net)
Formula: C100H139F3N24O35
Molecular: 2295.31
Sequence: FPRPGGGGNGDFEEIPEEYL
Also known as: CS-1433, HY-15664
What is Bivalirudin Trifluoroacetate?
Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.It inhibits both circulating and clot-bound thrombin,while also inhibiting thrombin-mediated platelet activation and aggregation.
Bivalirudin has a quick onset of action and a short half-life.It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS).It does not require a binding cofactor such as antithrombin and does not activate platelets.These characteristics make bivalirudin an ideal alternative to heparin.
Bivalirudin Trifluoroacetate Specification Specification
Appearance |
White powder |
Single Impurity (HPLC) |
0.5%max |
Amino Acid Composition |
±10% of theoretical |
Peptide Content (N%) |
≥80.0% |
Water Content (Karl Fischer) |
≤8.0% |
Acetate Content (HPIC) |
≤12.0% |
MS (ESI) |
Consistent |
Mass Balance |
95.0~105.0% |
Bivalirudin Trifluoroacetate Application
1) Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin.
2) Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
3) Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI).
4) Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI.
Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin.
Attention: Bivalirudin Trifluoroacetate is a custom product which need about 4 weeks to complete customization. MOQ 1g.
Peptides List
Notes: Click product to reach the product page
NO. |
Name |
Packing / CAS |
T-A001 |
MGF |
2mg / 5mg |
T-A002 |
PEG MGF |
2mg |
T-A003 |
CJC-1295 with DAC |
2mg |
T-A004 |
CJC-1295 without DAC |
2mg |
T-A005 |
PT-141 (Brmelanotice) |
10mg |
T-A006 |
Melanotan-1 (MT-1) |
10mg |
T-A007 |
Melanotan-II (MT-2) |
10mg |
T-A008 |
GHRP-2 |
5mg / 10mg |
T-A009 |
GHRP-6 |
5mg / 10mg |
T-A0010 |
Ipamorelin |
2mg |
T-A0011 |
Hexarelin |
2mg |
T-A0012 |
Sermorelin |
2mg |
T-A0013 |
Oxytocin |
1g / 2mg |
T-A0014 |
TB500 |
2mg |
T-A0015 |
Pentadecapeptide BPC 157 |
2mg |
T-A0016 |
HGH Fragment 176-191 |
2mg / 5mg |
T-A0017 |
IGF-1 LR3 |
0.1mg / 1mg |
T-A0018 |
Triptorelin |
2mg |
T-A0020 |
Tesamorelin |
2mg HIV |
T-A0021 |
Gonadorelin |
2mg / 10mg |
T-A0022 |
DSIP |
2mg |
T-A0023 |
Selank |
5mg |
T-A0024 |
Epitalon |
10mg |
T-A0025 |
AOD-9604 |
2mg |
T-A0026 |
ACE 031 |
1mg |
T-A0027 |
GDF-8 (Myostatin) |
1mg (-20ºC) |
T-A0028 |
Thyrotropin TRH |
1g |
T-A0029 |
Follistatin 315 |
1mg (-20ºC) |
T-A0030 |
Follistatin 344 |
1mg (-20ºC) |
T-A0031 |
Deslorelin |
20mg |
T-A0032 |
Adipotide |
2mg |
T-A0033 |
Argireline |
1g |
T-A0034 |
nonapeptide-1 |
1g |
T-A0035 |
SNAP-8 |
1mg |
T-A0036 |
Alarelin Acetate |
79561-22-1 |
T-A0037 |
Angiotensin Acetate |
58-49-1 |
T-A0038 |
Argpressin Acetate |
113-79-1 |
T-A0039 |
Aviptadil Acetate |
40077-57-4 |
T-A0040 |
Bivalirudin Trifluoroacetate |
128270-60-0 |
T-A0041 |
Deslorelin Acetate |
57773-65-6 |
T-A0042 |
Desmopressin Acetate |
16679-58-6 |
T-A0043 |
Eledoisin Acetate |
69-25-0 |
T-A0044 |
Eptifibatide Acetate |
148031-34-9 |
T-A0045 |
Felypressin Acetate |
56-59-7 |
T-A0046 |
GLP-1 (7-37) Acetate |
106612-94-6 |
T-A0047 |
Taspoglutide |
275371-94-3 |
T-A0048 |
Glucagon Hydrochloride |
16941-32-5 |
T-A0049 |
Lixisenatide |
320367-13-3 |
T-A0050 |
Gonadorelin Acetate |
34973-08-5 |
T-A0051 |
Leuprorelin Acetate |
53714-56-0 |
T-A0052 |
Lysipressin Acetate |
50-57-7 |
T-A0053 |
Nafarelin Acetate |
76932-56-4 |
T-A0054 |
Octreotide Acetate |
79517-01-4 |
T-A0055 |
Ornipressin Acetate |
3397-23-7 |
T-A0056 |
Secretin Acetate |
108135-74-8 |
T-A0057 |
Somatostatin Acetate |
38916-34-6 |
T-A0058 |
Splenopentin Acetate |
105184-37-0 |
T-A0059 |
Terlipressin Acetate |
14636-12-5 |
T-A0060 |
Teriparatide Acetate |
52232-67-4 |
T-A0061 |
Triptorelin Acetate |
57773-63-4 |
T-A0062 |
Vasopressin Acetate |
9034-50-8 |
T-A0063 |
Bate-Amyloid(1-42)human |
107761-42-2 |
T-A0064 |
Abarelix Acetate |
183552-38-7 |
T-A0065 |
Endothelin-1 Acetate |
117399-94-7 |
T-A0066 |
CRF (human, rat) Acetate |
86784-80-7 |
T-A0067 |
CRF (ovine) Trifluoroacetate |
79804-71-0 |
T-A0068 |
Dynorphin A (1-13) Acetate |
72957-38-1 |
T-A0069 |
Enfuvirtide Acetate (T-20) |
159519-65-0 |
T-A0070 |
Fertirelin Acetate |
38234-21-8 |
T-A0071 |
GRF (human) Acetate |
83930-13-6 |
T-A0072 |
Liraglutide |
204656-20-2 |
T-A0073 |
Dalmarelin Acetate |
61012-19-9 |
T-A0074 |
Nesiritide Acetate (BNP-32) |
114471-18-0 |
T-A0075 |
Pramlintide Acetate |
196078-30-5 |
T-A0076 |
Salmon Calcitonin Acetate |
47931-85-1 |
T-A0077 |
tesamorelin |
106612-94-6 |
T-A0078 |
Tetracosactide Acetate (ACTH 1-24) |
16960-16-0 |
T-A0079 |
Thymosin α1 Acetate |
14636-12-5 |
T-A0080 |
Thymosin β4 Acetate |
77591-33-4 |
T-A0081 |
Atosiban Acetate |
90779-69-4 |
T-A0082 |
Cetrorelix Acetate |
130143-01-0 |
T-A0083 |
Exenatide Acetate |
141732-76-5 |
T-A0084 |
Histrelin Acetate |
76712-82-8 |
T-A0085 |
Taltirelin Acetate |
103300-74-9 |
T-A0086 |
Vapreotide Acetate |
116430-60-5 |
T-A0087 |
Gonaderelin |
33515-09-2 |
T-A0088 |
Cecropin B |
80451-05-4 |
T-A0089 |
Oxytocin Acetate |
50-56-6 |
T-A0090 |
Sincalide |
25126-32-3 |
T-A0091 |
Protirelin |
24305-27-9 |
T-A0092 |
Ganirelix acetate |
123246-29-7 |